Monitoring democratic institutions through public records

Independent Agency Rules — Week of Dec 15, 2025

Some government agencies (like the FDA or EPA) are supposed to make decisions based on science and law, not politics. Can the President control what rules they write?

ConfirmedConcern

AI content assessment elevated

AI content assessment elevated with high P2 concern rate. Warrants close examination.

This week, the White House issued several executive orders that appear to suggest specific policy directions for independent government agencies, rather than allowing those agencies to follow their own scientific and legal processes. These appear to include orders that may direct specific outcomes in areas like artificial intelligence regulation, marijuana rescheduling, fentanyl classification, and proxy advisor oversight.

The AI executive order (Ensuring a National Policy Framework for Artificial Intelligence) is particularly notable because it instructs the FCC and FTC—agencies designed to operate independently from White House political direction—to adopt specific regulatory positions that override state laws. The administration says the goal is to promote innovation and create consistent national rules for AI. This might matter because independent agencies like the FCC and FTC exist precisely so that technical regulatory decisions are made based on expertise and law rather than political preference, and directing them toward predetermined outcomes could affect the independence of regulatory agencies designed to operate based on expertise and statutory mandates.

In another significant action, the President signed an executive order rescheduling marijuana from Schedule I to Schedule III (remarks here). Federal law assigns this decision to the Attorney General working with health and science agencies through a specific evaluation process. The President presented this as his own decision. It's possible the proper scientific review was completed beforehand—senior health officials, including the FDA Commissioner and NIH Director, were present at the signing, which could suggest prior consultation—but the framing as a presidential action rather than an agency determination is unusual.

A separate order designated fentanyl as a weapon of mass destruction, a novel classification that directs military and law enforcement to act accordingly. The administration cites fentanyl's extreme lethality as justification. This may function primarily as a political signal rather than creating binding legal consequences, but it does direct the Defense Department to update its chemical incident response plans, which could have real operational effects.

Meanwhile, the Government Accountability Office formally determined that a Commerce Department agency rewrote a $42.45 billion broadband grant program—removing congressional requirements like labor protections—without following the legal process for submitting new rules to Congress.

There are reasonable alternative explanations. Presidents routinely set policy direction for executive agencies, and some of these orders may reflect legitimate coordination rather than improper interference. Several orders use language like "shall consider" rather than "shall rescind," preserving at least formal agency discretion. Executive orders also frequently serve as starting points for policy discussions that trigger rather than replace normal agency processes. And some actions, like marijuana rescheduling, enjoy broad public support regardless of the procedural path.

Limitations: This is AI-generated analysis based on publicly available documents and cannot determine what internal deliberations occurred within agencies before these actions were taken.